Back to Tudor Investment Corp. Tudor Investment Corp.

MRNA

Showing 8 of 20 quarters

Position history for Tudor Investment Corp.Tudor Investment Corp.'s holdings in Moderna, Inc.

No. Tudor Investment exited its MRNA (Moderna) position in Q2 2026. Its Q1 2026 13F listed 143,115 shares worth $7.3M. Tudor Investment first reported MRNA in Q3 2020 and held it in 18 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$10.2M

Total Shares Change

-153,098

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$70.03
0
2026-Q1
Increased
143,115
+48.8%
$7.3M0.0%$50.80
38
2025-Q4
Decreased
96,206
-72.1%
$2.8M0.0%$29.49
0
2025-Q3
Decreased
344,551
-35.7%
$8.9M0.0%$25.83
0
2025-Q2
Increased
535,665
+69.3%
$14.8M0.0%$27.59
42
2025-Q1
Decreased
316,392
-10.6%
$9M0.0%$28.35
0
2024-Q4
Increased
353,865
+131.1%
$14.7M0.1%$41.58
45
2024-Q3
Increased
153,098
+23.1%
$10.2M0.0%$65.75
34

Other major holders of MRNA: Baillie Gifford & Co.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used